EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Enhancement of Prognostic Outcomes in Stage III Non-Small Cell Lung Cancer: A Retrospective Study on Neoadjuvant Immuno-Chemotherapy Followed by Definitive Chemo-Radiotherapy

Wenxin Ding, Yechen Ma, Hao Hu, Tian Xu, Hexin Duan, Jing Liang, Weiwei Liang, Hao Zhou, Xi Zhang, Zewen Song

Translational Oncology · 2025-06 · 56 · 102394

DOI: 10.1016/j.tranon.2025.102394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2025-06. Verfasst von Wenxin Ding und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Third Xiangya Hospital of Central South University, Central South University, Changsha, China; Department of Oncology, Xi…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Xiangya Hospital, Central South University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CarcinomaChemoradiotherapyImmunotherapyNeoadjuvant therapyNon-small-cell lung

Autor:innen und Institutionen

  • Department of Oncology, The Third Xiangya Hospital of Central South University, Central South University, Changsha, China; Department of Oncology, Xiangxi Autonomous Prefecture People's Hospital, Ji Shou University, Jis…
  • Department of Oncology, The Third Xiangya Hospital of Central South University, Central South University, Changsha, China.
  • Department of Oncology, The Second Xiangya Hospital of Central South University, Central South University, Changsha, China.
  • Department of Oncology, Xiangxi Autonomous Prefecture People's Hospital, Ji Shou University, Jishou, China.
  • Department of Oncology, The Third Xiangya Hospital of Central South University, Central South University, Changsha, China. Electronic address: xy3zhangxi@csu.edu.cn.

Förderung

  • Xiangya Hospital, Central South University

Zitieren

APA

Ding, W., Ma, Y., Hu, H., Xu, T., Duan, H., Liang, J., Liang, W., Zhou, H., Zhang, X., & Song, Z. (2025). Enhancement of Prognostic Outcomes in Stage III Non-Small Cell Lung Cancer: A Retrospective Study on Neoadjuvant Immuno-Chemotherapy Followed by Definitive Chemo-Radiotherapy. Translational Oncology, 56, 102394. https://doi.org/10.1016/j.tranon.2025.102394

Vancouver

Ding W, Ma Y, Hu H, Xu T, Duan H, Liang J, et al. Enhancement of Prognostic Outcomes in Stage III Non-Small Cell Lung Cancer: A Retrospective Study on Neoadjuvant Immuno-Chemotherapy Followed by Definitive Chemo-Radiotherapy. Translational Oncology. 2025;56:102394. doi:10.1016/j.tranon.2025.102394

BibTeX
@article{Ding2025,
  author = {Ding, Wenxin and Ma, Yechen and Hu, Hao and Xu, Tian and Duan, Hexin and Liang, Jing and Liang, Weiwei and Zhou, Hao and Zhang, Xi and Song, Zewen},
  title = {Enhancement of Prognostic Outcomes in Stage III Non-Small Cell Lung Cancer: A Retrospective Study on Neoadjuvant Immuno-Chemotherapy Followed by Definitive Chemo-Radiotherapy},
  journal = {Translational Oncology},
  year = {2025},
  volume = {56},
  pages = {102394},
  doi = {10.1016/j.tranon.2025.102394}
}
Kostenlos starten →